TVM Capital Life Science Venture Capital
Investing in Life Science Innovation
TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.
We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 130 life science companies in Europe, Canada and the United States, currently managing in excess of €900 million from more than 50 investors.
TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.